Can psychiatry cross the quality chasm? Improving the quality of health care for mental and substance use conditions.
Can psychiatry cross the quality chasm? Improving the quality of health care for mental and substance use conditions.
复制标题
DOI：
10.1176/ajp.2007.164.5.712
复制
发表时间：
2007-05
期刊：
影响因子：
--
通讯作者：
H. Pincus;Ann E. K. Page;B. Druss;P. Appelbaum;G. Gottlieb;M. England
中科院分区：
文献类型：
--
作者：
H. Pincus;Ann E. K. Page;B. Druss;P. Appelbaum;G. Gottlieb;M. England
2001年，医学研究所的一份开创性报告《跨越质量鸿沟：21世纪世纪的新卫生系统》提出了一项提高美国卫生保健质量的全面战略。这一策略在美国整体医疗保健系统中获得了相当大的吸引力，随后也引起了精神卫生界的关注。一份新的医学研究所报告，提高精神和物质使用条件的医疗保健质量，根据精神和物质使用医疗保健的独特特征，包括对患者决策能力和强制的担忧，检查了质量鸿沟战略。信息技术的使用和参与国家卫生信息基础设施的发展滞后，医疗服务更加分散，同时对共享临床信息的限制更多，获得诊断和治疗许可的提供者类型更多，更多的个人实践，以及一个不同结构的市场。本文总结了医学研究所对这些问题的分析和改善精神和物质使用卫生保健的建议，并讨论了精神科医生，精神病组织和其他精神和物质使用卫生保健领导人的精神病学实践和相关宣传工作的影响。
In 2001, a seminal Institute of Medicine report, Crossing the Quality Chasm: A New Health System for the 21st Century, put forth a comprehensive strategy for improving the quality of U.S. health care. This strategy attained considerable traction within the overall U.S. health care system and subsequent attention in the mental health community as well. A new Institute of Medicine report, Improving the Quality of Health Care for Mental and Substance Use Conditions, examines the quality chasm strategy in light of the distinctive features of mental and substance use health care, including concerns about patient decision-making abilities and coercion into care, a less developed quality measurement and improvement infrastructure, lagging use of information technology and participation in the development of the National Health Information Infrastructure, greater separations in care delivery accompanied by more restrictions on sharing clinical information, a larger number of provider types licensed to diagnose and treat, more solo practice, and a differently structured marketplace. This article summarizes the Institute of Medicine's analysis of these issues and recommendations for improving mental and substance use health care and discusses the implications for psychiatric practice and related advocacy efforts of psychiatrists, psychiatric organizations, and other leaders in mental and substance use health care.